Cronos Group Inc. (TSX:CRON)
Canada · Delayed Price · Currency is CAD | Market Cap | 1.72B |
| Revenue (ttm) | 184.36M |
| Net Income (ttm) | 50.28M |
| Shares Out | 382.89M |
| EPS (ttm) | 0.13 |
| PE Ratio | 34.24 |
| Forward PE | 45.82 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,053,721 |
| Average Volume | 223,424 |
| Open | 4.620 |
| Previous Close | 4.490 |
| Day's Range | 4.265 - 4.660 |
| 52-Week Range | 2.270 - 4.600 |
| Beta | 1.05 |
| RSI | 81.63 |
| Earnings Date | Feb 27, 2026 |
About Cronos Group
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada. [Read more]
Full Company ProfileNews
Cannabis stocks spike on reports Trump plans to ease federal pot restrictions
The rally marked one of the biggest single-day moves for cannabis stocks in years, snapping a prolonged slump.
Cannabis stocks surge on Trump's rumored Schedule 3 marijuana change. How high can pot shares get?
Multiple news reports this week said that President Trump is expected to reclassify marijuana's drug scheduling, which would lessen restrictions on its use and potentially allow companies that operate...
Trump Expected to Label Pot a Less Dangerous Drug
President Donald Trump is expected have his administration classify marijuana as a less dangerous drug, according to people familiar with the matter. This has been good news for pot stocks.
Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC
Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the in...
Tilray, Canopy And Other Weed Stocks Are Rallying In Friday Pre-Market— What's Going On?
The stock prices of major cannabis companies like Tilray Brands (NASDAQ: TLRY) and Canopy Growth (NASDAQ: CGC) skyrocketed 34.88% and 27.46%, respectively, in premarket trading on Friday, following ...
Cannabis stocks surge on reports Trump will reclassify marijuana; Tilray jumps 28%
President Donald Trump will significantly ease federal restrictions on marijuana and change its classification, according to the Washington Post and Axios. Cannabis stocks surged following the report.
Cannabis stocks surge as Trump signals shift on US marijuana policy
US-listed cannabis stocks saw sharp premarket gains on Friday after fresh reporting pointed to a possible change in federal marijuana policy under President Donald Trump. The development revived inves...
Cannabis stocks surge on report Trump seeks to ease restrictions
Shares of cannabis companies jumped on Friday after the Washington Post reported U.S. President Donald Trump is expected to push the government to dramatically loosen federal restrictions on marijuana...
3 Canadian Marijuana Stocks To Watch In 2026 That Could See A Massive Run
With 2026 showing to be a big year for reform, how will this impact marijuana stocks? Looking back over the years, it is clear that marijuana stocks have seen their best trading when positive news on ...
Cronos Group Plans Strategic Europe Expansion: How to Play the Stock?
CRON's planned CanAdelaar acquisition boosts its push into the Dutch adult-use cannabis market and highlights its strengthening international momentum.
Cronos Group (CRON) Signs Agreement to Acquire Netherlands Cannabis Leader
Cronos Group (CRON) Signs Agreement to Acquire Netherlands Cannabis Leader
Cronos to enter the Netherlands with acquisition of Europe's largest adult-use cannabis company
Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M 1 plus cash earnout of 0.5x normalized EBITDA in 2026 and 2027
Cronos Group (CRON) Enhances Lord Jones Line with New Cannabis Innovations
Cronos Group (CRON) Enhances Lord Jones Line with New Cannabis Innovations
Investing in Cannabis: Three Leading Stocks to Watch This November
The U.S. cannabis market continues to evolve as new legislative discussions, consumer trends, and business developments shape the industry's momentum. Although volatility remains, investors are increa...
3 Of The Best Marijuana Stocks To Buy For Possible Gains In 2026
The big question for marijuana stock investors is how the market will react to the newly passed bill to reverse the 2018 Farm Bill. A new bill was recently passed with language that essentially overtu...
4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill
Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington. Momentum Improves For 4 Cannabis Stocks The positive trend come...
4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill
Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington.
Congressional hemp restrictions threaten $28 billion industry, sending companies scrambling
The congressional funding bill included a THC cap that effectively bans most hemp products, a move industry leaders say threatens the $28 billion market. More than 300,000 jobs are at risk, with econo...
Cronos Group (CRON) Reports Record Q3 2025 Earnings
Cronos Group (CRON) Reports Record Q3 2025 Earnings
Cronos Group Inc. (CRON:CA) Q3 2025 Earnings Call Transcript
Cronos Group Inc. (CRON:CA) Q3 2025 Earnings Call November 6, 2025 8:30 AM ESTCompany ParticipantsHarrison AaronMichael Gorenstein - President, CEO &...
Cronos Group Inc (CRON) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
Cronos Group Inc (CRON) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Challenges
Q3 2025 Cronos Group Inc Earnings Call Transcript
Q3 2025 Cronos Group Inc Earnings Call Transcript
Cronos Group (CRON) Reports Record Q3 Revenue and Earnings
Cronos Group (CRON) Reports Record Q3 Revenue and Earnings
Cronos Group Inc (CRON) Q3 2025 Earnings: Revenue Misses Estimates at $36.3 Million
Cronos Group Inc (CRON) Q3 2025 Earnings: Revenue Misses Estimates at $36.3 Million
Cronos Group GAAP EPS of $0.07, revenue of $36.34M misses by $0.99M
Cronos Group reports Q3 GAAP EPS of $0.07 and $36.34M revenue, up 6.1% YoY but missing estimates.